MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (1082)	7/24/1998 2:54:00 PM
From: David Cathcart	Read Replies (1) of 1826

Tom Meyer called IR at MGI Pharma a few days ago and inquired about specifics of news releases regarding the phase II trials. Lori Weiman said that no information would be released regarding the results of the phase II trial until it was complete, 6 - 24 months from now. I guess if the drug begins to work miraculously well, phase II will go quickly (6 months) and they will move on to phase III. Let's hope for the best. David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next